Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Risk adjusted net present value: What is the current valuation of Acurx Pharmaceuticals's Ibezapolstat?
Ibezapolstat is a small molecule commercialized by Acurx Pharmaceuticals, with a leading Phase II program in Clostridioides difficile Infections (Clostridium...
Ibezapolstat by Acurx Pharmaceuticals for Clostridioides difficile Infections (Clostridium difficile Associated Disease): Likelihood of Approval
Ibezapolstat is under clinical development by Acurx Pharmaceuticals and currently in Phase II for Clostridioides difficile Infections (Clostridium difficile Associated...
Risk adjusted net present value: What is the current valuation of Acurx Pharmaceuticals's Ibezapolstat?
Ibezapolstat is a small molecule commercialized by Acurx Pharmaceuticals, with a leading Phase II program in Clostridioides difficile Infections (Clostridium...